Company Profile
Tactile Systems Technology, Inc. Stock Price, News & Catalysts
- Ticker:
- TCMD
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
24.59 USD (+1.61%)
Close
Last updated: August 17, 2026
551M USD
Market cap
Why the stock is moving
As of Aug 17, 2026, TCMD closed up 1.61% at $24.59. No new same-company headline was identified in the current news window.
Company overview
At-Home Chronic-Care Therapies
Tactile Medical develops and markets at-home therapies for underserved chronic conditions. Its products help patients manage long-term diseases outside hospitals and clinics while supporting clinician-directed treatment plans.
Lymphedema Portfolio
The company's Flexitouch systems deliver pneumatic compression therapy for lymphedema and related swelling disorders. Its acquisition of LymphaTech broadens the portfolio across the lymphedema-care continuum with measurement and monitoring capabilities.
Airway Clearance
AffloVest is a wearable high-frequency chest-wall oscillation system used by patients with chronic respiratory conditions who need airway-clearance therapy. A next-generation system expands Tactile Medical beyond its core lymphedema franchise.
Compression and Distribution
Tactile Medical also distributes complementary products such as the MyoSleeve wearable compression device. Its commercial model combines direct patient support, clinician engagement, reimbursement services and relationships with government and private payers.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Tactile Systems Technology, Inc. (TCMD)?
Tactile Systems Technology, Inc. (TCMD) most recently closed at 24.59 USD, a +1.61% move versus the previous session.
What is the market cap of Tactile Systems Technology, Inc. (TCMD)?
Tactile Systems Technology, Inc. currently has a market capitalization of 551M USD on BioPharmSignal.
What does Tactile Systems Technology, Inc. do?
At-Home Chronic-Care Therapies Tactile Medical develops and markets at-home therapies for underserved chronic conditions. Its products help patients manage long-term diseases outside hospitals and clinics while supporting clinician-directed treatment plans. Lymphedema Portfolio The company's Flexitouch systems deliver pneumatic compression therapy for...
On which exchange is TCMD stock listed?
Tactile Systems Technology, Inc. (TCMD) is associated with NASDAQ, United States, Biopharma.
What is At-Home?
At-Home Chronic-Care Therapies Tactile Medical develops and markets at-home therapies for underserved chronic conditions.
Which conditions is Tactile Systems Technology, Inc. targeting with At-Home?
Tactile Systems Technology, Inc. is associated with respiratory disease based on its company overview and current catalyst commentary.
What is Chronic-Care?
At-Home Chronic-Care Therapies Tactile Medical develops and markets at-home therapies for underserved chronic conditions.
What is Therapies?
At-Home Chronic-Care Therapies Tactile Medical develops and markets at-home therapies for underserved chronic conditions.